Suraksha Diagnostic Shareholding Pattern
- Market cap
- ₹1,625 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹224.68 – ₹421.27
As of Jun 2026, promoters held 48.50% of Suraksha Diagnostic, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
Suraksha Diagnostic shareholding pattern — frequently asked questions
What is the promoter holding in Suraksha Diagnostic?
Promoters held 48.50% of Suraksha Diagnostic as of Jun 2026.
How much do FIIs hold in Suraksha Diagnostic?
Foreign institutional investors held 18.40% of Suraksha Diagnostic as of Jun 2026.
How much do domestic institutions hold in Suraksha Diagnostic?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of Suraksha Diagnostic as of Jun 2026; mutual funds alone held 8.50%.
Who owns Suraksha Diagnostic?
As of Jun 2026, Suraksha Diagnostic's shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
- Suven Life Sciences Limited shareholding pattern
- Supriya Lifescience Limited shareholding pattern
- Syncom Formulations (India) Limited shareholding pattern
- Supreme Holdings & Hospitality (India) Limited shareholding pattern
- Syngene International Limited shareholding pattern
- Sun Pharmaceutical Industries Limited shareholding pattern
Trade Suraksha Diagnostic With ATS
Track SURAKSHA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.